STOCK TITAN

[Form 4] Milestone Pharmaceuticals Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Block, Inc. (ticker: XYZ) filed a Form 144 to notify the SEC of an intended sale of 2,800 shares of its common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE around 15 July 2025. At the stated aggregate market value of $190,568, the proposed sale equals roughly 0.0005 % of the company’s 615.0 million shares outstanding, indicating a very limited dilution effect.

The securities being sold were originally received as restricted-stock grants on three separate dates—02/20/2024 (1,442 shares), 11/20/2023 (961 shares) and 01/03/2023 (397 shares). No cash was paid at acquisition, implying the grants were part of equity-based compensation.

Over the last three months, the same reporting person executed nine open-market sales totaling 22,918 shares for gross proceeds of approximately $1.45 million. Even when combined with the new notice, total insider sales remain immaterial relative to Block’s share count and typical daily trading volume.

Form 144 requires the insider to certify that they possess no undisclosed material adverse information and, if relying on a Rule 10b5-1 plan, to disclose the plan-adoption date. No such plan date is provided in the filing.

Block, Inc. (ticker: XYZ) ha presentato un modulo Form 144 per notificare alla SEC l'intenzione di vendere 2.800 azioni del proprio capitale sociale. Le azioni saranno vendute tramite Morgan Stanley Smith Barney LLC alla NYSE intorno al 15 luglio 2025. Al valore di mercato aggregato dichiarato di 190.568 $, la vendita proposta corrisponde a circa lo 0,0005% delle 615,0 milioni di azioni in circolazione, indicando un effetto di diluizione molto limitato.

Le azioni in vendita sono state originariamente ricevute come concessioni di azioni vincolate in tre date distinte: 20/02/2024 (1.442 azioni), 20/11/2023 (961 azioni) e 03/01/2023 (397 azioni). Non è stato pagato alcun importo in contanti al momento dell'acquisizione, il che implica che le concessioni facevano parte di un compenso basato su azioni.

Negli ultimi tre mesi, la stessa persona segnalante ha effettuato nove vendite sul mercato aperto per un totale di 22.918 azioni, con un ricavo lordo di circa 1,45 milioni di $. Anche sommando questa nuova notifica, le vendite interne totali rimangono irrilevanti rispetto al numero di azioni di Block e al volume di scambi giornaliero tipico.

Il modulo Form 144 richiede all'insider di certificare di non possedere informazioni materiali negative non divulgate e, se si basa su un piano Rule 10b5-1, di indicarne la data di adozione. Nel deposito non è stata fornita alcuna data di adozione del piano.

Block, Inc. (símbolo: XYZ) presentó un Formulario 144 para notificar a la SEC sobre la intención de vender 2.800 acciones de sus acciones ordinarias. Las acciones se venderán a través de Morgan Stanley Smith Barney LLC en la NYSE alrededor del 15 de julio de 2025. Al valor de mercado agregado declarado de 190,568 $, la venta propuesta equivale aproximadamente al 0,0005% de las 615,0 millones de acciones en circulación, lo que indica un efecto de dilución muy limitado.

Los valores que se venden fueron recibidos originalmente como concesiones de acciones restringidas en tres fechas distintas: 20/02/2024 (1.442 acciones), 20/11/2023 (961 acciones) y 03/01/2023 (397 acciones). No se pagó dinero en efectivo en la adquisición, lo que implica que las concesiones formaban parte de una compensación basada en acciones.

En los últimos tres meses, la misma persona que reporta realizó nueve ventas en el mercado abierto por un total de 22.918 acciones, con ingresos brutos de aproximadamente 1,45 millones de $. Incluso sumando este nuevo aviso, las ventas internas totales siguen siendo insignificantes en relación con el número de acciones de Block y el volumen típico de negociación diaria.

El Formulario 144 requiere que el insider certifique que no posee información material adversa no divulgada y, si se basa en un plan Rule 10b5-1, que revele la fecha de adopción del plan. No se proporciona ninguna fecha de plan en la presentación.

Block, Inc. (티커: XYZ)는 SEC에 보통주 2,800주 매각 의사를 알리기 위해 Form 144를 제출했습니다. 해당 주식은 Morgan Stanley Smith Barney LLC를 통해 NYSE에서 2025년 7월 15일경에 매각될 예정입니다. 명시된 총 시장 가치는 190,568달러로, 제안된 매각은 회사의 6억 1,500만 주 발행 주식 중 약 0.0005%에 해당하여 희석 효과가 매우 제한적임을 나타냅니다.

매각되는 증권은 원래 세 차례에 걸쳐 제한 주식 부여로 받았으며, 각각 2024년 2월 20일(1,442주), 2023년 11월 20일(961주), 2023년 1월 3일(397주)입니다. 취득 시 현금 지급이 없었으므로, 이 부여는 주식 기반 보상의 일부였음을 의미합니다.

지난 3개월 동안 동일한 신고인은 9건의 공개 시장 매도를 실행해 총 22,918주를 매각했으며, 총 매출액은 약 145만 달러입니다. 이번 신규 신고를 합해도 내부자 매도 총액은 Block의 주식 수 및 일반적인 일일 거래량에 비해 미미한 수준입니다.

Form 144는 내부자가 미공개 중대한 부정적 정보를 보유하지 않았음을 인증하고, Rule 10b5-1 계획에 의존하는 경우 계획 채택일을 공개하도록 요구합니다. 이번 제출서에는 해당 계획 채택일이 명시되어 있지 않습니다.

Block, Inc. (symbole : XYZ) a déposé un formulaire 144 pour notifier à la SEC son intention de vendre 2 800 actions de ses actions ordinaires. Les actions seront vendues via Morgan Stanley Smith Barney LLC sur le NYSE aux alentours du 15 juillet 2025. À la valeur marchande agrégée déclarée de 190 568 $, la vente proposée représente environ 0,0005 % des 615 millions d'actions en circulation, indiquant un effet de dilution très limité.

Les titres vendus ont été initialement reçus sous forme de attributions d’actions restreintes à trois dates distinctes : 20/02/2024 (1 442 actions), 20/11/2023 (961 actions) et 03/01/2023 (397 actions). Aucun paiement en espèces n’a été effectué lors de l’acquisition, ce qui implique que ces attributions faisaient partie d’une rémunération en actions.

Au cours des trois derniers mois, la même personne déclarant a réalisé neuf ventes sur le marché ouvert totalisant 22 918 actions, pour un produit brut d’environ 1,45 million de $. Même en ajoutant cette nouvelle notification, le total des ventes d’initiés reste insignifiant par rapport au nombre d’actions de Block et au volume de transactions quotidien habituel.

Le formulaire 144 exige que l’initié certifie qu’il ne possède aucune information défavorable importante non divulguée et, s’il s’appuie sur un plan Rule 10b5-1, qu’il divulgue la date d’adoption du plan. Aucune date de plan n’a été fournie dans le dépôt.

Block, Inc. (Ticker: XYZ) hat ein Formular 144 eingereicht, um die SEC über den beabsichtigten Verkauf von 2.800 Aktien seiner Stammaktien zu informieren. Die Aktien sollen über Morgan Stanley Smith Barney LLC an der NYSE um den 15. Juli 2025 verkauft werden. Zum angegebenen aggregierten Marktwert von 190.568 $ entspricht der vorgeschlagene Verkauf etwa 0,0005 % der 615,0 Millionen ausstehenden Aktien des Unternehmens, was auf eine sehr begrenzte Verwässerungswirkung hinweist.

Die zu verkaufenden Wertpapiere wurden ursprünglich als Restricted-Stock-Zuweisungen an drei verschiedenen Terminen erhalten – 20.02.2024 (1.442 Aktien), 20.11.2023 (961 Aktien) und 03.01.2023 (397 Aktien). Beim Erwerb wurde kein Bargeld gezahlt, was darauf hindeutet, dass die Zuweisungen Teil einer aktienbasierten Vergütung waren.

In den letzten drei Monaten hat dieselbe meldende Person neun Verkäufe am offenen Markt mit insgesamt 22.918 Aktien durchgeführt, mit Bruttoerlösen von etwa 1,45 Millionen $. Selbst in Kombination mit der neuen Meldung bleiben die gesamten Insiderverkäufe im Verhältnis zur Aktienanzahl von Block und dem üblichen täglichen Handelsvolumen unbedeutend.

Formular 144 verlangt vom Insider die Bestätigung, dass keine nicht offengelegten wesentlichen negativen Informationen vorliegen und, falls auf einen Rule 10b5-1-Plan zurückgegriffen wird, die Angabe des Plan-Annahmedatums. Im Formular wurde kein solches Datum angegeben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Small Form 144 filing for 2,800 shares; negligible versus 615 M float—insider activity appears non-material.

The proposed sale represents less than one-thousandth of one percent of outstanding shares, so it is unlikely to pressure the stock price or alter earnings per share. Previous sales during the past quarter were similarly modest, totaling only 22,918 shares. Investors typically track insider behavior for sentiment cues, but the low absolute and relative volumes suggest no meaningful signal. I view the disclosure as routine compliance rather than an indicator of strategic or financial change.

TL;DR Routine insider liquidation of equity awards; governance risk minimal due to transparent Form 144 disclosure.

The filing fulfills regulatory obligations and confirms the seller’s affirmation that no undisclosed adverse information exists. Absence of a disclosed 10b5-1 plan date suggests discretionary selling, yet volumes are far below thresholds that would raise governance concerns or trigger aggregation limits under Rule 144(e). I classify the event as normal housekeeping for equity-compensated insiders.

Block, Inc. (ticker: XYZ) ha presentato un modulo Form 144 per notificare alla SEC l'intenzione di vendere 2.800 azioni del proprio capitale sociale. Le azioni saranno vendute tramite Morgan Stanley Smith Barney LLC alla NYSE intorno al 15 luglio 2025. Al valore di mercato aggregato dichiarato di 190.568 $, la vendita proposta corrisponde a circa lo 0,0005% delle 615,0 milioni di azioni in circolazione, indicando un effetto di diluizione molto limitato.

Le azioni in vendita sono state originariamente ricevute come concessioni di azioni vincolate in tre date distinte: 20/02/2024 (1.442 azioni), 20/11/2023 (961 azioni) e 03/01/2023 (397 azioni). Non è stato pagato alcun importo in contanti al momento dell'acquisizione, il che implica che le concessioni facevano parte di un compenso basato su azioni.

Negli ultimi tre mesi, la stessa persona segnalante ha effettuato nove vendite sul mercato aperto per un totale di 22.918 azioni, con un ricavo lordo di circa 1,45 milioni di $. Anche sommando questa nuova notifica, le vendite interne totali rimangono irrilevanti rispetto al numero di azioni di Block e al volume di scambi giornaliero tipico.

Il modulo Form 144 richiede all'insider di certificare di non possedere informazioni materiali negative non divulgate e, se si basa su un piano Rule 10b5-1, di indicarne la data di adozione. Nel deposito non è stata fornita alcuna data di adozione del piano.

Block, Inc. (símbolo: XYZ) presentó un Formulario 144 para notificar a la SEC sobre la intención de vender 2.800 acciones de sus acciones ordinarias. Las acciones se venderán a través de Morgan Stanley Smith Barney LLC en la NYSE alrededor del 15 de julio de 2025. Al valor de mercado agregado declarado de 190,568 $, la venta propuesta equivale aproximadamente al 0,0005% de las 615,0 millones de acciones en circulación, lo que indica un efecto de dilución muy limitado.

Los valores que se venden fueron recibidos originalmente como concesiones de acciones restringidas en tres fechas distintas: 20/02/2024 (1.442 acciones), 20/11/2023 (961 acciones) y 03/01/2023 (397 acciones). No se pagó dinero en efectivo en la adquisición, lo que implica que las concesiones formaban parte de una compensación basada en acciones.

En los últimos tres meses, la misma persona que reporta realizó nueve ventas en el mercado abierto por un total de 22.918 acciones, con ingresos brutos de aproximadamente 1,45 millones de $. Incluso sumando este nuevo aviso, las ventas internas totales siguen siendo insignificantes en relación con el número de acciones de Block y el volumen típico de negociación diaria.

El Formulario 144 requiere que el insider certifique que no posee información material adversa no divulgada y, si se basa en un plan Rule 10b5-1, que revele la fecha de adopción del plan. No se proporciona ninguna fecha de plan en la presentación.

Block, Inc. (티커: XYZ)는 SEC에 보통주 2,800주 매각 의사를 알리기 위해 Form 144를 제출했습니다. 해당 주식은 Morgan Stanley Smith Barney LLC를 통해 NYSE에서 2025년 7월 15일경에 매각될 예정입니다. 명시된 총 시장 가치는 190,568달러로, 제안된 매각은 회사의 6억 1,500만 주 발행 주식 중 약 0.0005%에 해당하여 희석 효과가 매우 제한적임을 나타냅니다.

매각되는 증권은 원래 세 차례에 걸쳐 제한 주식 부여로 받았으며, 각각 2024년 2월 20일(1,442주), 2023년 11월 20일(961주), 2023년 1월 3일(397주)입니다. 취득 시 현금 지급이 없었으므로, 이 부여는 주식 기반 보상의 일부였음을 의미합니다.

지난 3개월 동안 동일한 신고인은 9건의 공개 시장 매도를 실행해 총 22,918주를 매각했으며, 총 매출액은 약 145만 달러입니다. 이번 신규 신고를 합해도 내부자 매도 총액은 Block의 주식 수 및 일반적인 일일 거래량에 비해 미미한 수준입니다.

Form 144는 내부자가 미공개 중대한 부정적 정보를 보유하지 않았음을 인증하고, Rule 10b5-1 계획에 의존하는 경우 계획 채택일을 공개하도록 요구합니다. 이번 제출서에는 해당 계획 채택일이 명시되어 있지 않습니다.

Block, Inc. (symbole : XYZ) a déposé un formulaire 144 pour notifier à la SEC son intention de vendre 2 800 actions de ses actions ordinaires. Les actions seront vendues via Morgan Stanley Smith Barney LLC sur le NYSE aux alentours du 15 juillet 2025. À la valeur marchande agrégée déclarée de 190 568 $, la vente proposée représente environ 0,0005 % des 615 millions d'actions en circulation, indiquant un effet de dilution très limité.

Les titres vendus ont été initialement reçus sous forme de attributions d’actions restreintes à trois dates distinctes : 20/02/2024 (1 442 actions), 20/11/2023 (961 actions) et 03/01/2023 (397 actions). Aucun paiement en espèces n’a été effectué lors de l’acquisition, ce qui implique que ces attributions faisaient partie d’une rémunération en actions.

Au cours des trois derniers mois, la même personne déclarant a réalisé neuf ventes sur le marché ouvert totalisant 22 918 actions, pour un produit brut d’environ 1,45 million de $. Même en ajoutant cette nouvelle notification, le total des ventes d’initiés reste insignifiant par rapport au nombre d’actions de Block et au volume de transactions quotidien habituel.

Le formulaire 144 exige que l’initié certifie qu’il ne possède aucune information défavorable importante non divulguée et, s’il s’appuie sur un plan Rule 10b5-1, qu’il divulgue la date d’adoption du plan. Aucune date de plan n’a été fournie dans le dépôt.

Block, Inc. (Ticker: XYZ) hat ein Formular 144 eingereicht, um die SEC über den beabsichtigten Verkauf von 2.800 Aktien seiner Stammaktien zu informieren. Die Aktien sollen über Morgan Stanley Smith Barney LLC an der NYSE um den 15. Juli 2025 verkauft werden. Zum angegebenen aggregierten Marktwert von 190.568 $ entspricht der vorgeschlagene Verkauf etwa 0,0005 % der 615,0 Millionen ausstehenden Aktien des Unternehmens, was auf eine sehr begrenzte Verwässerungswirkung hinweist.

Die zu verkaufenden Wertpapiere wurden ursprünglich als Restricted-Stock-Zuweisungen an drei verschiedenen Terminen erhalten – 20.02.2024 (1.442 Aktien), 20.11.2023 (961 Aktien) und 03.01.2023 (397 Aktien). Beim Erwerb wurde kein Bargeld gezahlt, was darauf hindeutet, dass die Zuweisungen Teil einer aktienbasierten Vergütung waren.

In den letzten drei Monaten hat dieselbe meldende Person neun Verkäufe am offenen Markt mit insgesamt 22.918 Aktien durchgeführt, mit Bruttoerlösen von etwa 1,45 Millionen $. Selbst in Kombination mit der neuen Meldung bleiben die gesamten Insiderverkäufe im Verhältnis zur Aktienanzahl von Block und dem üblichen täglichen Handelsvolumen unbedeutend.

Formular 144 verlangt vom Insider die Bestätigung, dass keine nicht offengelegten wesentlichen negativen Informationen vorliegen und, falls auf einen Rule 10b5-1-Plan zurückgegriffen wird, die Angabe des Plan-Annahmedatums. Im Formular wurde kein solches Datum angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
PAPA JOSEPH C

(Last) (First) (Middle)
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420

(Street)
MONTREAL A8 H4M 2X6

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Milestone Pharmaceuticals Inc. [ MIST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 07/11/2025 A 100,000 A (1) 100,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Common Warrants (right to buy) $1.5 07/11/2025 A 100,000 (2) 07/11/2026 Common Shares 100,000 (1) 100,000 D
Series B Common Warrants (right to buy) $1.875 07/11/2025 A 100,000 (2) 07/11/2030 Common Shares 100,000 (1) 100,000 D
Explanation of Responses:
1. The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock.
2. Fully vested and exercisable.
/s/ Jason Minio, Attorney-in-Fact 07/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Block, Inc. (XYZ) shares are being sold under this Form 144?

The notice covers 2,800 common shares with an aggregate market value of $190,568.

When is the anticipated sale date for the Form 144 shares?

The filing cites an approximate sale date of 15 July 2025.

What percentage of Block’s outstanding shares does the sale represent?

It represents about 0.0005 % of the 615.0 million shares outstanding.

How much stock has the insider sold in the past three months?

According to the filing, 22,918 shares were sold for roughly $1.45 million in gross proceeds.

Were the shares being sold acquired through open-market purchases or grants?

All shares listed were originally received as restricted-stock grants from the issuer.
Milestone Pharmaceuticals

NASDAQ:MIST

MIST Rankings

MIST Latest News

MIST Latest SEC Filings

MIST Stock Data

120.29M
81.93M
0.66%
46.26%
1.39%
Biotechnology
Pharmaceutical Preparations
Link
Canada
MONTREAL